In confronting COVID misinformation I’ve mostly focused on inpatient treatment (this is my area of experience).
Recently I saw the FLCCC Long COVID “protocol” & oh boy is this some crazy non-evidence based prescriptions: HIV meds, steroids, diuretics, & of course ivermectin… 1/
First off, Long COVID is definitely “real” & can be severe.
Many studies have found persistent changes in immune cell phenotype & function, months after COVID infection.
Many great docs (@WesElyMD & others) are actively researching long COVID to improve our understanding.
2/
What concerns me is FLCC presenting “protocols” as proven treatments for long COVID.
Throwing 20 medications (9 are prescription 🟥) at a problem with minimal (or no) evidence is irresponsible. nature.com/articles/s4159…
As we will see, this is both unethical & likely harmful. 3/
What's the evidence for ivermectin in Long COVID? Basically nothing!
Despite ~200 studies on Long COVID, there are ZERO registered studies of IVM in long COVID.
Even among 86 IVM studies, the only thing even close is a small study looking at anosmia.
Not much evidence... 4/
What evidence do ivermectin proponents cite?
Kory references ONE uncontrolled study (really just an abstract;👀 below), where they gave n=33 people ivermectin at increasing doses & eventually they got better. Preprint posted in July 2020. Still unpublished.
Not compelling... 5/
Not only are there *ZERO* published RCTs of ivermectin in long COVID (or any in progress), there isn't even *ONE* controlled study.
The 'evidence base' for ivermectin in long COVID consists of one sketchy unpublished uncontrolled pre-print abstract of n=33 pts.
Thats it.
6/
On to the other aspects of the “protocol”:
Chronic steroids in COVID is a complex question. For outpatients who were never hypoxic there’s NO evidence for benefit (and quite possibly harm) with steroids. 7/
What’s the evidence for chronic steroids in post COVID outpatients?
Again basically nothing.
One RCT was done. It’s still unpublished so we don’t know if it helped or made things worse.
A few observational studies with contradictory results.
No good evidence for steroids 8/
This is not to say they is no role for steroids post-COVID. There *may* be a role for a longer steroid course in select patients (e.g. organizing pneumonia or fibrosis on chest CT) but no such subtlety is present in the FLCCC protocol.
Just 3 weeks of steroids for everyone!
9/
On to the next Rx: low dose naltrexone
There is a *theoretical* argument that naltrexone inhibits ERK1/2 signaling, which downregulates inflammation... again there is no clinical data that this is actually beneficial.
No studies on naltrexone whatsoever in long COVID.
10/
It randomized n=9 people to naltrexone vs n=9 to placebo.
It found no difference in ANY outcome.
It's the *ONLY* public data about naltrexone in COVID. 11/
On to the "second line therapies"
Fluvoxamine *IS* indeed a promising therapy for COVID. It's been shown to reduce hospitalizations/ED visits among outpatients who are newly diagnosed with COVID.
But does that mean it works for long COVID too?
12/
There are ZERO RCTs of fluvoxamine in post-COVID. There are also ZERO interventional or observational studies of fluvoxamine in long-COVID.
There is literally no evidence that fluvoxamine reduces symptom severity or duration (or *anything*) in long covid. 13/
So far this "long COVID protocol" is 0/4 for actual evidence among prescription meds.
What about #5: atorvastatin?
Statins probably DO reduce inflammation & reduce (long term) mortality in most people but the evidence in COVID is surprisingly weak. hopkinsmedicine.org/news/newsroom/…
14/
There actually ARE well designed studies trying to figure out *IF* statins help in long COVID.
The fact that there are studies ongoing means that there is equipoise about whether these statins work or not.
I'm excited to see the results of STRONGER & HEAL-COVID but I'm not holding my breath. Until results are published there is NO evidence for statins in long COVID.
16/
On to the next & oddest med in this protocol: Maraviroc.
Maravaric is a CCR5 chemokine receptor antagonist, used to treat HIV infection by blocking its entry into CCR5 expressing cells.
Maraviroc isn't generic & it's expensive: typically over $2000 for the 300mg BID dose.
17/
As with everything else in the this protocol, there are exactly ZERO studies of Maravaric in long COVID.
No RCTs. No interventional studies. No observational studies. Nothing. Nada.
Pay $2k/month for 2 months (which insurance definitely won't cover) based on no evidence.
18/
Interestingly, there were 2 early stage trials of maraviroc in severe COVID, w/ the hypothesis that blocking CCR5 would reduce neutrophil infiltrates in 🫁 preventing/mitigating ARDS
This is a nice *idea* for an inpatient clinical trial. NOT an outpatient treatment protocol 19/
But here's where it gets even sketchier...
The protocol says consider "getting an InCellDx test to assess long hauler index"
Basically, InCellDx used a 14 cytokine panel to do a tiny study in 121 post-COVID pts vs 29 health controls
They found tiny cytokine changes but via the magic of ML created an overfit unvalidated random forest model to spit out "long haul covid index" frontiersin.org/articles/10.33… 21/
InCellDx's science is 'meh' but their marketing is top notch!
InCellDx turned their cytokine test & "long haul COVID index" into quite the product.
They created a COVID support group "COVID long haulers" to push the test.
They also appear to have partnered w/ FLCCC & others. 22/
Never mind the inconvenient question: "WHY do this expensive cytokine test for long COVID?"
What clinical implications does that test have? There's absolutely no evidence to start or stop *any* therapy based on the result.
At best this is a research tool. At worst a scam.
23/
Another point about bad data science:
The group used a technique called SMOTE (synthetic minority over sampling technique). I’ve used this before. It’s great for rare events but it’s super weird to use it to oversample healthy controls. Why not get more volunteers?
A big 🚩
Talking to people who have been through it:
After the $360 test, InCellDx charges $200 for a video consultation, then $300 for more tests.
Then a referral to a FLCCC approved doc ($200+) followed by $2k/month for maraviroc.
Seems like InCellDx is cashing in on long COVID.
24/
As for another prescription included in this protocol: high dose diuretics (spironolactone).
Starting spironolactone at higher than recommended dose *without checking electrolytes* is dangerous & potentially malpractice.
As a pulmonologist, I know this med very well & there are reasons to think it *could* help alleviate dyspnea after COVID pneumonia.
But what’s the actual evidence for montelukast in long COVID?
Once again not very much…
26/
There actually are ongoing clinical trials of montelukast in long COVID, such as the well named E-SPERANZA study in 🇪🇸 clinicaltrials.gov/ct2/show/NCT04…
This trial is predicated upon a 13 person uncontrolled pilot study. That n=13 study is the sum total of evidence for Montelukast btw 27/
One article proposes using montelukast because of “the lack of effective therapy, chemo prevention, & vaccination.”
Oh wait we have all of those things now. Maybe we don’t need montelukast…?
This raises an important point. The best way to prevent long COVID is vaccination! 28/
Speaking of effective: there is evidence that vaccination can improve long COVID symptoms!
In an observational study of n=163 people with severe long COVID 8 months after infection, 95% reported improved/stable symptoms 1 month following vaccination pubmed.ncbi.nlm.nih.gov/34029484/
29/
If the FLCCC protocol is what NOT to do, how *should* we treat long COVID?
Instead of a one size fits all kitchen sink approach involving 20+ meds (each with potential side effects), it recommends a stepwise approach based on symptoms, timing, & severity.
There are actual proven therapies for post ICU syndrome & sequelae of critical illness. 27/
If you are suffering from long COVID, there are reputable doctors who can help. There are centers of excellence (such as the @CIBScenter) & clinical trials you can enroll in (see the 🧵 above).
Don’t get taken advantage of by discredited scam artists pushing “protocols”.
28/
Summary:
-the “I-RECOVER protocol” of 20 meds is dangerous nonsense. None of these interventions is based on robust clinical trials.
-taking an unproven combination of meds could make you feel worse not better.
-don’t get conned into paying these quacks for this “protocol”
fin/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#HurricaneHelene damaged the factory responsible for manufacturing over 60% of all IV fluids used in the US, leading to a major national shortage.
As clinicians what can we do to about the #IVFluidShortage and how can we prevent this crisis from happening again?
A thread 🧵 1/
There are many things we can do as clinicians to improve ICU care & reduce IVF use.
1️⃣Don't order Maintenance IV Fluid!
Almost no patient actually needs continuous IV fluids.
Most either need resuscitation (e.g. boluses) or can take fluid other ways (PO, feeding tube, TPN).
2/
Frequently if someone is NPO overnight for a procedure, MIVF are ordered.
This is wrong for two reasons.
We are all NPO while asleep & don't need salt water infusions!
We should be letting people drink clears up to TWO HOURS before surgery, per ASA.
New favorite physiology paper: Central Venous Pressure in Space.
So much space & cardio physiology to unpack here including:
- effects of posture, 3g shuttle launch, & microgravity on CVP
- change in the relationship between filling pressure (CVP) & LV size
- Guyton curves! 1/
To measure CVP in space they needed two things:
📼 an instrument/recorder that could accurately measure pressure despite g-force, vibration, & changes in pressure. They built & tested one!
🧑🚀👩🚀👨🚀 an astronaut willing to fly into space with a central line! 3 volunteered! 2/
The night before launch they placed a 4Fr central line in the median cubital vein & advanced under fluoro.
🚀The astronauts wore the data recorder under their flight suit during launch.
🌍The collected data from launch up to 48 hrs in orbit. 3/
Did he have a head CT? What did it show?
Did he have stitches? Tetanus shot?
The NYT ran nonstop stories about Biden’s health after the debate but can’t be bothered to report on the health of someone who was literally shot in the head?
To the people in the replies who say it’s impossible because of “HIPPA” 1. I assume you mean HIPAA 2. A normal presidential candidate would allow his doctors to release the info. This is exactly what happened when Reagan survived an assassination attempt. washingtonpost.com/obituaries/202…
My advice to journalists is to lookup tangential gunshot wounds (TGSW).
Ask questions like:
- what imaging has he had?
- what cognitive assessments?
- has he seen a neurosurgeon or neurologist?
- he’s previously had symptoms like slurred speech, abnormal gait - are these worse?
If you intubate you need to read the #PREOXI trial!
-n=1301 people requiring intubation in ED/ ICU were randomized to preoxygenation with oxygen mask vs non-invasive ventilation (NIV)
-NIV HALVED the risk of hypoxemia: 9 vs 18%
-NIV reduced mortality: 0.2% vs 1.1%
#CCR24
🧵 1/
Hypoxemia (SpO2 <85%) occurs in 10-20% of ED & ICU intubations.
1-2% of intubations performed in ED/ICU result in cardiac arrest!
This is an exceptionally dangerous procedure and preoxygenation is essential to keep patients safe.
But what’s the *BEST* way to preoxygenate? 2/
Most people use a non-rebreather oxygen mask, but because of its loose fit it often delivers much less than 100% FiO2.
NIV (“BiPAP”) delivers a higher FiO2 because of its tight fit. It also delivers PEEP & achieves a higher mean airway pressure which is theoretically helpful! 3/
Results from #PROTECTION presented #CCR24 & published @NEJM.
- DB RCT of amino acid infusion vs placebo in n=3511 people undergoing cardiac surgery w/ bypass.
- Reduced incidence of AKI (26.9% vs 31.7% NNT=20) & need for RRT (1.4% vs 1.9% NNT=200)
Potential game changer!
🧵 1/
I work in a busy CVICU & I often see AKI following cardiac surgery.
Despite risk stratification & hemodynamic optimization, AKI remains one of the most common complications after cardiac surgery with bypass.
Even a modest reduction in AKI/CRRT would be great for my patients. 2/
During cardiac surgery w/ bypass, renal blood flow (RBF) is reduced dramatically. This causes injury, especially in susceptible individuals.
But what if we could use physiology to protect the kidneys?
Renal blood vessels dilate after a high protein meal increasing RBF & GFR! 3/